Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy

  • 1,
  • 2,
  • 3, 4,
  • 5,
  • 4,
  • 7,
  • 3, 6,
  • 6,
  • 2,
  • 6, 8 and
  • 1Email author
Cardiovascular Diabetology201817:49

https://doi.org/10.1186/s12933-018-0696-x

  • Received: 29 March 2018
  • Accepted: 29 March 2018
  • Published:

The original article was published in Cardiovascular Diabetology 2015 14:33

Correction to: Cardiovasc Diabetol (2015) 14:33 https://doi.org/10.1186/s12933-015-0196-1

The author found errors in Table 1 after publication of the original article [1].

The corrected Table 1 is presented in this erratum.
Table 1

Characteristics of the study groups

 

Diabetes without retinopathy (n = 159)

Diabetic with retinopathy (n = 153)

p

Sex—men, n (%)

82 (51.6%)

76 (49.7%)

0.824

Non caucasian, n (%)

7 (4.40%)

7 (4.58%)

1.000

Age (years)

59.0 [48.5;66.0]

61.0 [54.0;68.0]

0.012

Disease duration (years)

6.00 [2.50;10.0]

11.0 [6.00;20.0]

< 0.001

Insulin treatment, n (%)

20 (12.6%)

84 (54.9%)

< 0.001

Smoking (current/past/never) (n)

32/55/71

30/44/79

0.442

Antiplatelet treatment, n (%)

47 (29.6%)

71 (46.4%)

0.003

Dyslipidaemia, n (%)

67 (42.1%)

78 (51.0%)

0.147

Hypertension, n (%)

80 (50.3%)

103 (67.3%)

0.003

Systolic BP (mmHg)

134 [123;145]

143 [133;159]

< 0.001

Diastolic BP (mmHg)

76.0 [70.5;83.0]

77.5 [68.8;85.2]

0.752

Heart rate (b/min)

75.0 [68.0;82.0]

77.0 [70.0;86.0]

0.076

Body mass index (kg/m2)

30.3 [27.4;34.0]

31.1 [28.3;35.0]

0.247

Waist (cm)

103 [96.8;111]

107 [101;114]

0.007

Haemoglobin A1c (%)

7.00 [6.50;7.90]

8.10 [7.20;9.10]

< 0.001

Total-cholesterol (mg/dL)

184 [163;206]

181 [163;204]

0.988

HDL-cholesterol (mg/dL)

47.0 [40.0;57.0]

50.5 [42.0;60.2]

0.03

LDL-cholesterol (mg/dL)

109 [90.4;130]

105 [86.5;128]

0.268

Triglycerides (mg/dL)

118 [89.5;169]

116 [83.0;168]

0.617

Creatinine (mg/dL)

0.79 [0.69;0.92]

0.79 [0.68;0.93]

0.797

Urinary albumin/creatinine ratio (mg/g)

5.80 [3.19;10.9]

12.4 [6.00;32.7]

< 0.001

Data are presented as the median values and interquartile ranges

BP blood pressure

Notes

Declarations

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Endocrinology and Nutrition, Health Sciences Research Institute and University Hospital Germans Trias i Pujol, Badalona, Spain
(2)
Department of Ophthalmology, Hospital Universitari Arnau de Vilanova, Lleida, Spain
(3)
Department of Endocrinology and Nutrition, Hospital Universitari Arnau de Vilanova, Lleida, Spain
(4)
Institut de Recerca Biomedica de Lleida, University of Lleida, Lleida, Spain
(5)
Department of Endocrinology and Nutrition, Institut d’Investigacions Biomediques August Pi Suñer, CIBER de Diabetes y Enfermedades Metabólicas asociadas, Hospital Clinic, 08036 Barcelona, Spain
(6)
Unitat de Detecció i Tractament de Malalties Aterotrombòtiques, Hospital Universitari Arnau de Vilanova, Lleida, Spain
(7)
Department of Neurology, Hospital Universitari Arnau de Vilanova, Lleida, Spain
(8)
Department of Nephrology, Hospital Universitari Arnau de Vilanova, Lleida, Spain

Reference

  1. Alonso N, Traveset A, Rubinat E, Ortega E, Alcubierre N, Sanahuja J, Hernández M, Betriu A, Jurjo C, Fernández E, Mauricio D. Type 2 diabetes-associated carotid plaque burden is increased in patients with retinopathy compared to those without retinopathy. Cardiovasc Diabetol. 2015;14:33. https://doi.org/10.1186/s12933-015-0196-1.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement